Surprised to see a relatively large article and bold headline today in Newsday reporting on this news. While it may not be huge news, any exposure in the media is welcome. Although Newsday is a Long Island paper it is also available to many in NYC. Although there is nothing new to shake the rafters in the article it does provide a profile of the company.
Certainly not what I was hoping for . As was pointed out by another questioner long time investors are still around and many like myself are hard to change. I have been on board for years because I believe in the merits of EECP. I have also held hope for their new monitors and products I would have liked to hear why the medical device segment continues to be so disappointing? Ma answered my question directly and made it clear it is now only a fraction of total revenue, but offered no explanation as to why and nothing in the way of a game plan to turn things around. I find, unfortunately, that most information provided at these conference calls is bland and generic. The same type of response was given in regard to a reverse split inquiry. Yes it may be considered but there is no time table for one at this time.
So it is what it is. Vasomedical may soon require a new name because its profile as a medical device company does not seem appropriate any longer.